Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alessia, Provera"'
Autor:
Alessia Provera, Cristina Vecchio, Anteneh Nigussie Sheferaw, Ian Stoppa, Deepika Pantham, Umberto Dianzani, Salvatore Sutti
Publikováno v:
Heliyon, Vol 10, Iss 15, Pp e35338- (2024)
Metabolic dysfunction associated steatotic liver disease (MASLD) is a progressive pathological condition characterized by the accumulation of triglycerides within hepatocytes that causes histological changes, which, in the long run, might compromise
Externí odkaz:
https://doaj.org/article/165392ea03ad43e38e826b1f18cedd4d
Autor:
Beatrice Foglia, Salvatore Sutti, Stefania Cannito, Chiara Rosso, Marina Maggiora, Alice Casalino, Claudia Bocca, Erica Novo, Francesca Protopapa, Naresh Naik Ramavath, Alessia Provera, Alessandro Gambella, Elisabetta Bugianesi, Frank Tacke, Emanuele Albano, Maurizio Parola
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD), previously non-alcoholic fatty liver disease (NAFLD), is a leading cause of chronic liver disease worldwide. In 20%–30% of MASLD patients, the disease progresses to metabol
Externí odkaz:
https://doaj.org/article/d6a5de90512a4675bd04fbf010588c35
Autor:
Alessia Provera, Naresh Naik Ramavath, Laila Lavanya Gadipudi, Casimiro Luca Gigliotti, Elena Boggio, Cristina Vecchio, Ian Stoppa, Roberta Rolla, Renzo Boldorini, Mario Pirisi, Carlo Smirne, Emanuele Albano, Umberto Dianzani, Salvatore Sutti
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Background and aimsInducible T-cell Co-Stimulator (ICOS) present on T-lymphocytes and its ligand ICOSL expressed by myeloid cells play multiple roles in regulating T-cell functions. However, recent evidence indicates that reverse signalling involving
Externí odkaz:
https://doaj.org/article/f05f4f2e19024bb6aff14a0bd147f227
Autor:
Erica Novo, Andrea Cappon, Gianmarco Villano, Santina Quarta, Stefania Cannito, Claudia Bocca, Cristian Turato, Maria Guido, Marina Maggiora, Francesca Protopapa, Salvatore Sutti, Alessia Provera, Mariagrazia Ruvoletto, Alessandra Biasiolo, Beatrice Foglia, Emanuele Albano, Patrizia Pontisso, Maurizio Parola
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease worldwide. In 20-30% of patients, NAFLD can progress into non-alcoholic steatohepatitis (NASH), eventually leading to fibrosis, cirrhosis and hepatocellular c
Externí odkaz:
https://doaj.org/article/0b2f8a9cdce347ea8e3573b42a3dc766
Autor:
Naresh Naik Ramavath, Laila Lavanya Gadipudi, Alessia Provera, Luca C. Gigliotti, Elena Boggio, Cristina Bozzola, Emanuele Albano, Umberto Dianzani, Salvatore Sutti
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The liver capacity to recover from acute liver injury is a critical factor in the development of acute liver failure (ALF) caused by viral infections, ischemia/reperfusion or drug toxicity. Liver healing requires the switching of pro-inflammatory mon
Externí odkaz:
https://doaj.org/article/1518e1223ad74f0f999f958a4de6a36f
Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis
Autor:
Laila Lavanya Gadipudi, Naresh Naik Ramavath, Alessia Provera, Chris Reutelingsperger, Emanuele Albano, Mauro Perretti, Salvatore Sutti
Publikováno v:
Clinical Science, 136(9), 643-656. Portland Press Ltd.
Annexin A1 (AnxA1) is an important effector in the resolution of inflammation which is involved in modulating hepatic inflammation in nonalcoholic steatohepatitis (NASH). In the present study, we have investigated the possible effects of treatment wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90986f63f36c59aa8b32e5b480238b9a
https://doi.org/10.1042/cs20211122
https://doi.org/10.1042/cs20211122
Autor:
Erica, Novo, Andrea, Cappon, Gianmarco, Villano, Santina, Quarta, Stefania, Cannito, Claudia, Bocca, Cristian, Turato, Maria, Guido, Marina, Maggiora, Francesca, Protopapa, Salvatore, Sutti, Alessia, Provera, Mariagrazia, Ruvoletto, Alessandra, Biasiolo, Beatrice, Foglia, Emanuele, Albano, Patrizia, Pontisso, Maurizio, Parola
Non-alcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease worldwide. In 20-30% of patients, NAFLD can progress into non-alcoholic steatohepatitis (NASH), eventually leading to fibrosis, cirrhosis and hepatocellular c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c8d4f5f4f991602dd260e575817de1f
http://hdl.handle.net/11577/3451529
http://hdl.handle.net/11577/3451529
Autor:
Emanuela Agosti, Simone Reano, Antonio Colasanto, Davide Raineri, Alessia Provera, S. Sutti, Nicoletta Filigheddu, Naresh Naik Ramavath, J. D. Coisson, Laila Lavanya Gadipudi, Marco Arlorio, Emanuele Albano, Flavia Prodam, Annalisa Chiocchetti
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44bf697c9b29d06309f5474655296223
https://doi.org/10.1530/endoabs.73.pep7.8
https://doi.org/10.1530/endoabs.73.pep7.8